Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for prevention of postoperative atrial fibrillation after CABG
IRCT20241121063794N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Atrial fibrillation (AFib) comparing Dapagliflozin with Placebo (2 arms). Primary endpoints: Incidence of postoperative atrial fibrillation rhythm, Gender and 8 more. Started Apr 2025; status: completed.
02
Drugs
dapagliflozin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20241121063794N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241121063794N1.